Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital

被引:9
|
作者
Zhang, Di [1 ]
Cui, Kai [2 ]
Wang, Taotao [1 ]
Shan, Yuanyuan [1 ]
Dong, Haiyan [1 ]
Feng, Weiyi [1 ]
Ma, Chen [1 ,3 ]
Dong, Yalin [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Pharm, Yanta West Rd 277, Xian 710061, Shaanxi, Peoples R China
[2] Xian Univ Posts & Telecommun, Dept Management Econ, Xian, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Clin Lab, Xian, Shaanxi, Peoples R China
来源
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES | 2018年 / 12卷 / 08期
关键词
Pseudomonas aeruginosa; carbapenem resistantance; risk factors; mortality; ANTIMICROBIAL RESISTANCE; BACTEREMIA; ENTEROBACTERIACEAE; SELECTION;
D O I
10.3855/jidc.10150
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is rapidly emerging as a life-threatening nosocomial infection. In this study, we aimed to identify risk factors, especially antibiotic use and co-carriage with other bacteria for CRPA infection or colonization. Methodology: A retrospective study was conducted in the First Affiliated Hospital of Xi'an Jiaotong University, which involved a cohort of patients with Pseudomonas aeruginosa infection or colonization from January 2014 to June 2016. Univariate analysis and multivariate analysis were performed to estimate the risk factors of CRPA occurrence. Results: Eight hundred and eighty-eight patients were included in the study. More than 50% of the risk factors were associated with CRPA infection or colonization according to univariate analysis (P < 0.05), such as invasive procedures, co-carriage with Gram-negative pathogens, and prior treatment with some antibiotics. However, only prior exposure to carbapenems (OR: 8.005; CI: 4.507-14.217, P < 0.001), the days of carbapenems treatment (OR: 1.190; CI: 1.073-1.272; P < 0.001), and co-carriage with Escherichia coli (OR: 1.824; CI: 1.005-3.310, P = 0.048) were considered independent risk factors by multivariate analysis. A higher mortality was found among patients with CRPA infection or colonization (P < 0.05). Conclusions: Risk factors for CRPA infection or colonization were prior exposure to carbapenems, the days of carbapenems treatment, and co-carriage with Escherichia coli. The prevalence of CRPA could be influenced by Gram-negative pathogens, especially in Escherichia coli, and it need more researches. Moreover, restrictions in the clinical use of carbapenems should be taken into account.
引用
收藏
页码:642 / 648
页数:7
相关论文
共 50 条
  • [31] Carbapenem-resistant Enterobacteriaceae in hematological patients: Outcome of patients with Carbapenem-resistant Enterobacteriaceae infection and risk factors for progression to infection after rectal colonization
    Zhang, Lining
    Zhai, Weihua
    Lin, Qingsong
    Zhu, Xiaofan
    Xiao, Zhijian
    Yang, Renchi
    Zheng, Yizhou
    Zhang, Fengkui
    Li, Shangzhu
    Wang, Chuan
    Feng, Sizhou
    Han, Mingzhe
    Wang, Jianxiang
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (04) : 527 - 529
  • [32] Virulence Factors Of Carbapenem-Resistant Pseudomonas aeruginosa In Hospital-Acquired Infections In Mansoura, Egypt
    El-Mahdy, Rasha
    El-Kannishy, Ghada
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 3455 - 3461
  • [33] Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
    Li, Shuang
    Jia, Xiaojiong
    Li, Congya
    Zou, Hua
    Liu, Hang
    Guo, Yuanbiao
    Zhang, Liping
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 1225 - 1235
  • [34] The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis
    Chen, Zhihui
    Xu, Ziqin
    Wu, Hongmei
    Chen, Le
    Gao, Shengchun
    Chen, Yangfang
    AMERICAN JOURNAL OF INFECTION CONTROL, 2019, 47 (06) : 677 - 682
  • [35] Seven-year change of prevalence, clinical risk factors, and mortality of patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a Chinese teaching hospital: a case-case-control study
    Kong, Haifang
    Liu, Yong
    Yang, Ling
    Chen, Qianqian
    Li, Yanchun
    Hu, Zhidong
    Feng, Xuequan
    Chai, Yamin
    Dong, Zuoliang
    FRONTIERS IN MICROBIOLOGY, 2025, 16
  • [36] Ceftazidime/Avibactam for the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Infection in Lung Transplant Recipients
    Chen, Juan
    Liang, Qiqiang
    Ding, Shuo
    Xu, Yongshan
    Hu, Yanting
    Chen, Jingyu
    Huang, Man
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 2237 - 2246
  • [37] Risk factors for carbapenem-resistant Enterobacterales infection among hospitalized patients with previous colonization
    Chen, Xia
    Zhou, Mao
    Yan, Qun
    Jian, Zijuan
    Liu, Wenen
    Li, Hongling
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (11)
  • [38] Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection
    Vitkauskiene, Astra
    Dambrauskiene, Asta
    Cerniauskiene, Kristina
    Rimdeika, Rytis
    Sakalauskas, Raimundas
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (03) : 213 - 218
  • [39] Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: A meta-analysis
    Li, Jihong
    Li, Yuanyuan
    Song, Ning
    Chen, Yuan
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 21 : 306 - 313
  • [40] Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study
    Gomez Rueda, Viviana
    Zuleta Tobon, John Jairo
    COLOMBIA MEDICA, 2014, 45 (02): : 54 - 60